• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Anti-inflammatory therapy cuts risk of lung cancer worldpharmanews
    August 29, 2017
    In most clinical trials for cancer therapy, investigators test treatments in patients with advanced disease.
  • UCB, Dermira plan psoriasis filing for Cimzia in Q3 pharmatimes
    January 20, 2017
    UCB and Dermira are expecting to file anti-inflammatory Cimzia for psoriasis in the third quarter of this year, after the drug's strong performance in a late-stage trial involving patients with severe chronic plaque forms of the skin disease.
Previous page 1 2 Next page

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service